BATAINDIA01 Jan 1900 
₹
0.00 (0.00 % )
Lowest Today
Highest Today
Prev. Close
Today’s Open
52 Week High
52 Week Low
BUY
SELL
To Invest in 
BATAINDIA01 Jan 1900
₹
0.00 (0.00 % )
1D
1W
1M
3M
30-May-2024
27-Jun-2024
25-Jul-2024

Future Price

Contract Price (30-May-2024)
₹+0.00 (+0.00%)
Spot Price
Premium(+) / Discount(-)
%

Key Details (30-May-2024)

Lowest Today
Highest Today
Open Interest
OI Change
(0%)
Average Traded Price
Lot Size
Prev. Close
Today’s Open
Volume
Turnover
Rollover Cost
Rollover Cost %
0.00

Latest News

Can Nifty 50 climb to 23K this week after US Fed downplaying rate hike buzz
Indian stock market today: Global equities witnessed a strong rebound after the US Fed meeting, which signaled a willingness to go for a rate cut once there is an ease in the inflation concerns. On Dalal Street, the frontline Indian indices and broad market witnessed buying interest during morning deals, which are still underway. However, the Nifty 50 index is somehow not able to breach.
02 May 2024 | 12:51 PM
📢 Benchmark indices open on a flat note today; Nifty near 22,650
📈 Amid mixed global cues, benchmark indices started on a flat note today.
📊 At 9:16 AM, the Sensex gained 150.34 points or 0.20% at 74,633.12 and the Nifty was up 50.10 points or 0.22% at 22,654.95.
📢 Indiamart Intermesh (⬆️4.15%), Cholamandalam Investment and Finance Company (⬆️3.73%) and Hindustan Petroleum (⬆️3.54%) appeared as the top performers on the Nifty50 at open.
02 May 2024 | 09:24 AM
📢 Benchmark indices open on a flat note today; Nifty near 22,650
📈 Amid mixed global cues, benchmark indices started on a flat note today.
📊 At 9:16 AM, the Sensex gained 150.34 points or 0.20% at 74,633.12 and the Nifty was up 50.10 points or 0.22% at 22,654.95.
📢 Indiamart Intermesh (⬆️4.15%), Cholamandalam Investment and Finance Company (⬆️3.73%) and Hindustan Petroleum (⬆️3.54%) appeared as the top performers on the Nifty50 at open.
02 May 2024 | 09:24 AM
Morgan Stanley, India Life Sciences funds acquire control of Maiva Pharma
Maiva Pharma, an injectables contract development and manufacturing organisation (CDMO), has raised about Rs 1,000 crore in primary and secondary funding from a fund managed by Morgan Stanley Private Equity Asia and India Life Sciences Fund-IV, the company said. The two investors have jointly acquired a controlling stake in Maiva from existing investors and have infused primary capital.
02 May 2024 | 03:30 PM
Buy InterGlobe Aviation; target of Rs 4700: Emkay Global Financial
Emkay Global Financial's research report on InterGlobe AviationThe stock, despite its recent strong runup, still has legs, given that competitors Air India/Akasa’s order books have higher exposure to Boeing (737 Max, facing safety issues) which implies risk to their near-term capacity adds. Indigo, backed by a steady stream of Airbus deliveries, can gain mkt share & improve yields.
02 May 2024 | 03:27 PM
view more news
BUY
SELL